Lataa...
Role of posaconazole in the treatment of oropharyngeal candidiasis
Posaconazole is the newest azole antifungal approved by the US Food and Drug Administration, and possesses a broad spectrum of activity against numerous yeasts and filamentous fungi. It is available as an oral suspension and is generally well tolerated by patients, but gastrointestinal absorption is...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3108746/ https://ncbi.nlm.nih.gov/pubmed/21694893 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|